Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand
New Zealand Medical Journal · 22.03.2024 · 137 (1592) · 14-21
DOI: 10.26635/6965.6379 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 22.03.2024. Verfasst von Philippa van Dantzig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand. Hauptthemen laut MEDLINE: Giant Cell Arteritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
aim: Giant cell arteritis (GCA) is the most common primary vasculitis in adults over 50 years of age. Our primary objective was to assess the incidence and prevalence of GCA in Waikato in a bid to deepen our understanding of the epidemiology of GCA in Aotearoa New Zealand. methods: From January 2014 to December 2022, cases of GCA were identified prospectively and retrospectively through temporal artery ultrasound request lists and temporal artery biopsy histology reports. Using electronic health records, data were collected retrospectively on patient demographics and clinical features. These were used to calculate the incidence, prevalence and standardised mortality ratio (SMR) of GCA in Waikato. results: There were 214 patients diagnosed with GCA over the 9-year period. The majority of patients were European (93.9%, 201/214) with Māori patients being significantly younger than European patients. The mean annual incidence of clinical GCA was 14.7 per 100,000 people over 50 years (95% confidence interval [CI] 12.7–16.6). The SMR was 1.18 (95% CI 0.83–1.52). conclusion: This is the largest study to date on the epidemiology of GCA in Aotearoa New Zealand. The incidence of GCA is comparable to other studies performed in Aotearoa New Zealand and appears to be stable over time. GCA is uncommon in Māori, Pacific Islander and Asian ethnic groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand.
- Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Hamilton, New Zealand.
- University of Waikato, Hamilton, New Zealand.
- Rheumatology Department, Te Whatu Ora, Waikato Hospital, Hamilton, New Zealand; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Zitieren
APA
van Dantzig, P., Quincey, V., Kurz, J., Ming, C., Kamalaksha, S., & White, D. (2024). Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand. New Zealand Medical Journal, 137(1592), 14-21. https://doi.org/10.26635/6965.6379
Vancouver
van Dantzig P, Quincey V, Kurz J, Ming C, Kamalaksha S, White D. Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand. New Zealand Medical Journal. 2024;137(1592):14-21. doi:10.26635/6965.6379
BibTeX
@article{vanDantzig2024,
author = {van Dantzig, Philippa and Quincey, Vicki and Kurz, Jason and Ming, Caroline and Kamalaksha, Sujatha and White, Douglas},
title = {Epidemiology of giant cell arteritis in Waikato, Aotearoa New Zealand},
journal = {New Zealand Medical Journal},
year = {2024},
volume = {137},
number = {1592},
pages = {14--21},
doi = {10.26635/6965.6379}
}
EUVIMED